News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Corporation (IVX) Provides Gabapentin Update


10/19/2005 5:11:47 PM

IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today that Alpharma Inc. has triggered the start on their 180-day exclusivity period with the launch of their gabapentin 100, 300 and 400 mg capsules.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES